Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, discussions highlight the study’s importance, with many citing the 70% effectiveness figure and referencing authoritative sources like NEJM, which underscores a collective effort to understand and communicate vaccine performance against Omicron. The tone and choice of words reflect a serious, evidence-based engagement aimed at clarifying vaccine benefits despite challenges posed by the variant.
Most discussions acknowledge the study's findings, supporting the vaccine’s moderate effectiveness against Omicron and emphasizing booster importance.
Posts demonstrate high interest by citing specific data, studies, and official sources, showing engagement with detailed evidence.
Discussions reference multiple studies, include direct quotes from research, and critique other claims, indicating deep involvement.
The widespread references to reputable publications and emphasis on vaccine efficacy suggest these discussions influence public perception and policy considerations.
さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/iNkzrOhmkL
More details on these studies here: 1- https://t.co/FScL7hdKnx 2- https://t.co/d9Rhguh4wa https://t.co/Z0Hnw4AQIx
Ómicron no ayuda con la Ola de pánico: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/uPTd8DGH8R
@iVangisteren @Luketheduke1960 @Tijn24572196 @Daan52863960 @HaHaGentherapie @DirkvanLinth @jhn_steen @groenevink @edowestra @siepsaysitagain @RealistBotNL Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/oMfrHcCoOt 2/2
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/KtgL0SGSXo
@Porcupine666 @njmidm @BrabantNick @Celine_student @iris46384809 @Epi_genetics @Marc_Veld @Petra_Lambers @mevrouw_Judith @SjefVugt @mholkers @DeGeneraal_NL @ProfessorWonka @Singing_BumbleB @OlifaNT @marcel_niekus @GarageRemus @Bepweetveel @WappieWerpen @SebastienDeVos @Poisoni51179073 @ErikvdB4 @mus_nico @Saint_William_ @ZelfBart @muumi_tweets @Yvon66 @HTillaert @DrDavidNL @TisjeboyRay @T4antiw4ppie @Rbor700 @ale_rolan @Arnodg @vanvalkenhoef @Jeepsteratti @metertje_of_2 @KlaasvanDijk5 @Jan__He @gdisselkoen @ReinsmaC @BekkeringChris @hapelensrob @zeg_maar_Niks @GVDBossche Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/oMfrHcCoOt 2/2
Latest data as of January 10, 2022, shows that the third vaccine dose improves protection against Omicron infection and hospitalization, though transmission reduction is limited. The effectiveness of vaccines against…
This video evaluates how well the BNT162b2 vaccine (Pfizer) protects against the Omicron variant of COVID-19 in South Africa. Results suggest the vaccine is less effective at preventing infection but still offers…
@AliasMork Was hat das mit meiner Ausgangsfrage zu tun? Aber du kannst dich gerne weiterbilden ;) https://t.co/dOdPbiGmdu https://t.co/Cs5W05S6Z7
RT @jsm2334: @JudexVeritatis @Goldfiinger77 @Anazacco @GVDBossche Here are some more that include data during the Omicron era: 6. https://t…
@JudexVeritatis @Goldfiinger77 @Anazacco @GVDBossche Here are some more that include data during the Omicron era: 6. https://t.co/2vuLDpHN4L 7. https://t.co/Q7QvUM6LSP 8. https://t.co/4Zgwz8PaAx 9. https://t.co/TaE8gxFLPF Let me know if you want some more from the pre-Omicron era.
@Harriner @DrPuerner https://t.co/nFvE1LNpdL
@KonradMZK @MaxymilianLv @PaweMarkiewicz7 @wojt91 @jakubwiech https://t.co/zSbSQmDQ79 umiesz w linki klikać?
@blobfish_68 @DrPuerner https://t.co/nFvE1LNpdL
@AlexanderPikar @Stefan_btw @DrPuerner https://t.co/nFvE1LNpdL
@pausibau @DrPuerner https://t.co/nFvE1LNpdL
@frei_sind @DrPuerner https://t.co/nFvE1LNpdL
@ENirenberg There are numerous studies (of course severe disease is not consistently defined) -- here are some papers/preprints for BA.1: https://t.co/O7xG5CAMhr https://t.co/4Zgwz96dCx https://t.co/hqOCIZQjeH
@angelocasa @MarkDavidsonAfr Yep the studies are published with all that info available. A requirement for approval actually! Would you like to see? Some examples… https://t.co/xZ08dGqdYV ; https://t.co/HkWxM9fD0o ; https://t.co/U9ltkpa23h
@OldNurse7 @ViennaVince @DrPuerner https://t.co/nFvE1LMRod
@wendymoo @latexsalesmen @MarkDavidsonAfr It’s base rate fallacy, survival bias and study design error in looking at the graph the way you have. Ie: you can’t look at this cross sectionally after a few waves of infection vs vaccination. Rather, this is what you do: https://t.co/oGAb8UzAwg; https://t.co/Mzy1tolMyb
@Z8ZLQj8YJEfwai8 治験時には「感染」防止ではなく、「発症」防止 「重症化」防止 しか検討していないのは事実です！ 社長コメントが何時のものか分かりませんが、 ファイザー社の南アフリカでの試験では オミクロン株の重症化予防効果は従来株より低い70％と報告しています(NEJM誌)。 https://t.co/siB9rSTXGU https://t.co/YqwDpjt69I
@Yggdras00251321 @cit_dechue @MarcAntoineSai5 @Edouard_Pinson @NicolasYvan2 @AntoinetteColby @obourdais @idrissaberkane @DeBunKerEtoiles @lonnibesancon @etatsdechoc_ @nathanpsmad Je cherche l'étude sur la cohorte de l'essai initial quand j'ai un moment si tu veux. Ici voilà les résultats du Pfizer en Afrique du Sud. https://t.co/OgUINEB5Yp
@RegulaAnates @Charlos79 @PowerMan4Evr @ScottAdamsSays Explain to me which N value in this study is "underpowered": https://t.co/1CI4IQkmVA Explain it like I'm 5.
@kursinwundern @oki1504 @DrPuerner @FrankfurtZack @UllmannMdB @BMG_Bund @TinoSorge https://t.co/nFvE1LMRod
@fragmichdoch23 @DrPuerner https://t.co/mRueRjNb46
@Sunshiney2021 @nannaraga @Suellentrinkt @HollsteinM @katjadler @micLIBERAL Wie sie schon sagten: hol schuld. Ich bringe Ihnen die Belege, dass sie hier Unsinn verzapfen. In Form von aktuellen Studien. Und Ihre Quellen zu Ihren Behauptungen?? https://t.co/G1ZskKD9sw https://t.co/ftYgemw6Bn https://t.co/3nb5AnyW4P
RT @dogarrett: OMICRON E VACINA Apesar da Omicron causar mais infecções entre vacinados (sem falar em não vacinados), estudo na África do S…
@carstenpeitz @derBonnerJung @prof_walace @Tim_Roehn https://t.co/nFvE1LMRod
@DetlefSchober @reisig10982111 @DrPuerner https://t.co/nFvE1LMRod
@Ukum01824657 @NOELI7O @DrPuerner https://t.co/nFvE1LMRod
@didszuleit @DrPuerner @Karl_Lauterbach https://t.co/nFvE1LMRod
@KatharinaLuder @DrPuerner @Karl_Lauterbach Hier habe ich Ihnen ebenfalls gepostet: https://t.co/nFvE1LMRod
@KatharinaLuder @DrPuerner @Karl_Lauterbach https://t.co/nFvE1LMRod
@forzahorizon000 @JanaSchwiek @DrPuerner Dann halt Omikron: https://t.co/nFvE1LMRod
@Pitzki11 @KalksteinNir @moomin05492341 https://t.co/znwowd5Z1b
@VerenaMaria82 @DrPuerner https://t.co/nFvE1LMRod
@Steff744 @RobertMai13 @DrPuerner @Markus__Lanz https://t.co/nFvE1LMRod
@KarlHei40571337 @diebasispartei @DSattelmaier @anwaelte_afa https://t.co/nFvE1LMRod
@SoKati_ @GerberundAdrian @Tim_Roehn https://t.co/nFvE1LMRod
@lili3614 @DIVIZIO1 C'est la seule étude sérieuse sur la vaccination, on peut trouver d'autres études comparatives sur omicron, mais les données sont biaisées : https://t.co/3Bz1dMaX9Q
@SAPBongGo @tolrobinpadilla @RamonTulfoII @SenImeeMarcos @bongbongmarcos @DOHgovph @ntfcovid19ph @FDAPhilippines @senatePH @loren_legarda @piacayetano @risahontiveros @migzzubiri @SenFNTolentino @jvejercito Effectiveness of BNT162b2 on Omicron in
@PraxisMarlene @godiva_doc @DrFHoffmann @DrPuerner ZB die https://t.co/s5l45VG5Or
@Zwitscher_Chris @DrPuerner https://t.co/s5l45VG5Or
@sanctuary_truth @Intuitiona0815 https://t.co/nFvE1LMRod
@rockinrio9111 @KlocknerMarcus @DrPuerner https://t.co/nFvE1LMRod
@Thuringus @MStruppi @fader70 @DrPuerner https://t.co/nFvE1LMRod
@MZitronelli @Sunshiney2021 @skorpionin1982 @Erwin_Rueddel Die tritt schon nach 2 Dosen auf, nach 3 ist sie besonders gut: https://t.co/nFvE1LMRod
@mmk56303682 @IDoNotConsent7 @waynerohde Even if the Vaccine was only 30% effective against preventing infection that still means you are less likely to be infected and less likely to infect other than not vaccinated at all https://t.co/gX8YUqKg4b
@JanCEbert @GoldsteinBlum @M_T_Franz https://t.co/nFvE1LMRod
@bonn0759 @RalphStanger https://t.co/nFvE1LMRod
@RDisarray @DrPuerner https://t.co/nFvE1LMRod
@maromano13 @twittonreg @DrPuerner @BR24 https://t.co/nFvE1LNpdL
@Heike13882121 https://t.co/nFvE1LMRod
@ManfredR20 @CyclicSun @MarionaMarione @Karl_Lauterbach https://t.co/nFvE1LMRod
@viechbaderin @DominikHenkel1 @Andy31050315 @DrPuerner https://t.co/nFvE1LMRod
@Ursel08151 @DominikHenkel1 @Andy31050315 @DrPuerner https://t.co/nFvE1LMRod
@Pedro39884887 @Suicide_Med @DrPuerner https://t.co/nFvE1LMRod
@P______Nguyen @CatCorn18364893 @DocLazris @TheEliKlein @The_OtherET @DrJBhattacharya @VPrasadMDMPH @louiebfree was still high during Delta, a bit lower for omicron During the proxy omicron period, we found a vaccine effectiveness of 70% (95% confidence interval [CI], 62 to 76), a finding that was supported by the results of all sensitivity tests. https://t.co/90m6Du7Dn4
@TUFF_Movie @andrepphd @syaxmanxtha_da @Lewislama @atRachelGilmore and there are many studies which continue to show the vaccine is highly effective against severe illness, even for Omicron. The 12% claim was for kids and infection, not illness https://t.co/90m6Du7Dn4 "During the proxy omicron period, we found a vaccine effectiveness of 70%"
@Gehirnzelle0 @LeonDash2020 @Casalingo4 @ergroovt @DrPuerner https://t.co/nFvE1LMRod
@christi21684520 @lil_onacci @reitschuster https://t.co/nFvE1LMRod
@Wiester10 @Rytfydsh @TheMarieOakes I didnt reply to you 2% travel claim, only the 12% bogus claim. "During the proxy omicron period, we found a vaccine effectiveness of 70%" https://t.co/90m6Du7Dn4
@BasilthBassel @Tim_Roehn https://t.co/nFvE1LMRod
@KaMi0684 @pupsikacka @Tim_Roehn https://t.co/nFvE1LMRod
@pmcdunnough @MathewMoisture Here it is. https://t.co/MM6QRcZltp
RT @dogarrett: OMICRON E VACINA Apesar da Omicron causar mais infecções entre vacinados (sem falar em não vacinados), estudo na África do S…
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/MOutZW9DfH
RT @angie_rasmussen: Polio is just one example of how vaccines work to reduce R even when they imperfectly prevent infection. What does the…
@SNewstreet @ersguderjunge81 @DrPuerner https://t.co/nFvE1LMRod
@Elon49943563 @DrPuerner https://t.co/nFvE1LMRod
RT @angie_rasmussen: Polio is just one example of how vaccines work to reduce R even when they imperfectly prevent infection. What does the…
@JuliaKopp13 @PlEsc2 @spasskultur @DrPuerner https://t.co/nFvE1LMRod
@kade_christina @marcfriedrich7 @Karl_Lauterbach Dann schauen wir mal gemeinsam was die Impfung so leistet: https://t.co/nFvE1LMRod
@Globo29598913 @FischerJorgen @MarcusHirschbe1 @marcfriedrich7 @Karl_Lauterbach https://t.co/nFvE1LMRod
@Metafork93 @AndreEEE330 @MarcusHirschbe1 @marcfriedrich7 @Karl_Lauterbach https://t.co/nFvE1LMRod
@quermann_ @FischerJorgen @MarcusHirschbe1 @marcfriedrich7 @Karl_Lauterbach https://t.co/nFvE1LMRod
RT @balkraix: @Inconforme75 @BeatrizTalegon 153-https://t.co/5ZBEnvbMqh 154-https://t.co/siLIqugKAq 155-https://t.co/rh7RWP8a0C 156-https:/…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
@Inconforme75 @BeatrizTalegon 153-https://t.co/5ZBEnvbMqh 154-https://t.co/siLIqugKAq 155-https://t.co/rh7RWP8a0C 156-https://t.co/kx3BGMbpAU 157-https://t.co/riDdJKvZvX 158-https://t.co/UGpgP1gvnZ 159-https://t.co/3YbNBswxat 160-https://t.co/6BkQ1KWP0j 161-https://t.co/WxoQfD9MCB 162-https://t.co/tE87vBlD0e
RT @dogarrett: OMICRON E VACINA Apesar da Omicron causar mais infecções entre vacinados (sem falar em não vacinados), estudo na África do S…
RT @dogarrett: OMICRON E VACINA Apesar da Omicron causar mais infecções entre vacinados (sem falar em não vacinados), estudo na África do S…
@DarrellSpins @gerdosi https://t.co/MM6QRcZltp They found about 70% against hospitalization with omicron, and 93% for preceding variants. This seems in the right ballpark. There are a lot of bogus studies pushing boosters that end up showing that 2x and 3x don't work ... https://t.co/e0lrICpWr4
@tw_3348 @Covert_PRGirl @TGAgovau https://t.co/90m6Du7Dn4 During the proxy omicron period, we found a vaccine effectiveness of 70%
@WahnSager @sabi_ri @systemanalysen @DrCatlicious @19CherryB97 @bundesalex @dzdwidv @Hosenmaus1 @WolfmannotJack @threepwood1990 @humbughund Collie S, Champion J, Moultrie H, Bekker L-G, Gray G, Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa. N Engl J Med 2022; 386:494-496 3/
@HeinzlerM @AzaTehut @HolgerRauh @Tagesspiegel https://t.co/nFvE1LMRod
@drm148 @LaLaLaLeah4 @Smi71548280 @sterling_nacho @kellyrudyk Here's a Nature editorial from last year: https://t.co/9j9hA5aLMm Here's a study from Feb: https://t.co/BBuGSm7MTH
@willyl0wman @VoiceOfFranky Medical researchers are capable of doing exactly that. This paper found vaccines to be about 70% effective at preventing infection by omicron, which isn't particularly high: https://t.co/I86y98T8hG.
@ProfKlarname @DrPuerner https://t.co/nFvE1LMRod
@meat_popsicle5e @RayBurtonSAS https://t.co/ummCZkzDIp
@gyan_chakshu @DFisman Oh #poodle, if you ask nicely I can send more #studies! Here's one, just because you're so gosh darn cute. https://t.co/HghpulTpPh
RT @dogarrett: OMICRON E VACINA Apesar da Omicron causar mais infecções entre vacinados (sem falar em não vacinados), estudo na África do S…
@Kessy19721 @Tim_Roehn https://t.co/s5l45VG5Or
@LoremIp20497219 @StockDoc69 @DrPuerner https://t.co/s5l45VoupR
@Dion__Dixon @_MartinHagen https://t.co/3gHbcj4Qtd
@LigerRoar @Lyra_Lushi @Der_Obergute https://t.co/3gHbcj5oiL
@stainedglassdig @JCAP201 @EricMMatheny https://t.co/P2i6wbiSl7.
@MrPink19841984 @PWBBOOMER @Hicksyfern @JumboJones56 @logos2992 @PortGunman @CraigKellyMP @LizChatwin @AstraZeneca PS. here's the study
@MrPink19841984 @PWBBOOMER @Hicksyfern @JumboJones56 @logos2992 @PortGunman @CraigKellyMP @LizChatwin @AstraZeneca Oh I'm sure you can teach me by reading this one and telling me what it says right? https://t.co/DrMozV1Cuj
@MrPink19841984 @Hicksyfern @JumboJones56 @logos2992 @PortGunman @CraigKellyMP @LizChatwin @AstraZeneca Oh I'm just following your example, I shared a whole page of NSW provided studies on the effectiveness of vaccines that you blew off as Government data. But fuck it coz I'm feeling generous: https://t.co/DrMozV1Cuj
@NoToNWOAgenda @AfD_Wf @KayRytter @AfDimBundestag @Alice_Weidel https://t.co/s5l45VG5Or
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
@Alexand71368996 @DrPuerner @Karl_Lauterbach https://t.co/s5l45VG5Or
@StephanHuber11 @HelgaMuggenburg @DrPuerner @Karl_Lauterbach https://t.co/nFvE1LMRod
@Theinexplicbl76 @hip934 @AreOhEssEyeEe RWE is your friend. https://t.co/2JLYesDZoH
@BOBSOIGNANT @sylvain_massot @ayoAu7 @Le___Doc Et bien allez y partagez vos données au lieu de prendre de haut. 70% d'efficacité contre l'hospitalisation avec omicron en Afrique du sud: https://t.co/avClRrTPuo 68% efficacité en uk pour l'étude "SARS-CoV-2 variants of concern and variants under investigation in England"
27/509 NEJM Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa During the proxy omicron period, a vaccine effectiveness of 70% (95% CI 62 - 76) https://t.co/hWIHJ0YUBf
@iVangisteren @Luketheduke1960 @Tijn24572196 @Daan52863960 @HaHaGentherapie @DirkvanLinth @jhn_steen @groenevink @edowestra @siepsaysitagain @RealistBotNL Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/oMfrHcCoOt 2/2
@FCavernes @VictorSinclair3 Pour que vous lisiez au moins une étude en voici une. Revenez lorsque vous aurez lu? https://t.co/eMYwTBcop0
@MRJINJGLE80 @VictorSinclair3 Commencez par en lire une et on verra ensuite? https://t.co/eMYwTBcop0
@SarJulen @VictorSinclair3 Alors ça c'est pour du 2 doses en afrique du sud... des études à 3 doses existent faisant état dune meilleure affectivité. Je vous en envoie si vous survivez. Bonne lecture. https://t.co/eMYwTBcop0
@Porcupine666 @njmidm @BrabantNick @Celine_student @iris46384809 @Epi_genetics @Marc_Veld @Petra_Lambers @mevrouw_Judith @SjefVugt @mholkers @DeGeneraal_NL @ProfessorWonka @Singing_BumbleB @OlifaNT @marcel_niekus @GarageRemus @Bepweetveel @WappieWerpen @SebastienDeVos @Poisoni51179073 @ErikvdB4 @mus_nico @Saint_William_ @ZelfBart @muumi_tweets @Yvon66 @HTillaert @DrDavidNL @TisjeboyRay @T4antiw4ppie @Rbor700 @ale_rolan @Arnodg @vanvalkenhoef @Jeepsteratti @metertje_of_2 @KlaasvanDijk5 @Jan__He @gdisselkoen @ReinsmaC @BekkeringChris @hapelensrob @zeg_maar_Niks @GVDBossche Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/oMfrHcCoOt 2/2
@LizaGirl63 @HaircutSpock @KayVonPaul @Bigsmiffy438 @david_haddaway @ChrisJohnsonMD @swedishchf @ginapro @HomeHelpfulRN @SHurrell1 @mcfunny @BurgerLab12 @FrankDElia7 @irishman7771 @markmcdougall13 @pawley_robert @andylumm @jamesgordon4th @SassyGirlD1 @BrowningNeelyn @thatsnotmine125 @Bebert701 @MdRisette @ADreyzen @JSAHolmes @nyob7714 @WendyOrent @florida_reb @RTheatheist @trpdo @fredwibblington @Nycweatherrepor @Alex_on_A14 @UKCryptoKing247 @Kathmarval @Whackamole__ @NateWeymouth @ENirenberg @carlsmythe @ZKForTre @ghoppe @Tiffany_Stuff @barryjohnreid21 @IainMulady @Pope_Bane @wendy_Lynnette @MRJenny8675309 @SwaledaleMutton @BlainEillimatta @CoreyEBeverage Here, #bunny: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/HghpulTpPh Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents https://t.co/rYXSEOz4oZ Aaaaand for data from to
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/CBj0ChLdgR
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/XlC9IzpVQS
Controlled scientific study and the New England Journal of Medicine. "Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM" https://t.co/CAjiuzZbZJ
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/uS84TnIs9k
@ECwBhJUqASxQBkO @hiroyoshimura NEJM Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/5m0QBHehtp BMJ Fact check—how many patients in hospital are unvaccinated? https://t.co/mpfeCneMJv Covid-19: An urgent call for global “vaccines-plus” action https://t.co/GeGyTSLEvw
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
@medicKim85 @jonasgahrstore 1 Collie S, Moultrie H, Bekker L, Gray G. Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa. N Engl J Med 2021. UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England.Update on hospitalisation and vaccine
More details on these studies here: 1- https://t.co/FScL7hdKnx 2- https://t.co/d9Rhguh4wa https://t.co/Z0Hnw4AQIx
@trader_hashang 南アのデータでは2回接種後2週間以上経過している人の入院(≒重症?)が121/6290なので約2%ですね。 年齢や基礎疾患によって2%より高くなる人もいますので、あとはご自身の判断かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/5RHEid8WMY https://t.co/9y2ydWC3yX
Population-based, retrospective study. 2 doses Pfizer 70% effective in preventing hospitalization during omicron period, 93% during delta. Highlights importance of booster dosages and development of variant-specific vaccines. Via https://t.co/qKhwv6GX0M https://t.co/Jx5GqirmXt
@SassyGirlD1 @WendyOrent @BlueLionBlog @4thEchelon22 @Juanita87722370 @ChrisJohnsonMD @TinFoilAwards @HawkInATX @TheFrankmanMN @FrankDElia7 @khan_we_kick_it @crabb_vicki @keithccurtis @WaitingForPerot @handmadekathy @heartattackvax @doritmi @lewbloch @SkepticalMutant @Vbalance03 @KStateTurk @BGLTHMND @Monstercoyliar @PuddleJumper358 @carlsmythe @natedoromal @mcfunny @cappsie @TeddyFreddy11 @TruthTwt @ellethejambo @KassandraSeven @krebiozen @immunotoxPhD @painless42 @LazarusLong13 @Twanky_Resists @lizditz @R_Good_Fellow @mimetic_ @kidoctr @drhenrymyman @kfunk937 @Felicea @CBereel @2ManyOfUs @BetteanneCamag1 @hempyhope @Landau_18901 @Rogue_Soc_Psych Because vaccines aren't either 0% or 100% effective, which I've noticed antivaxxers cannot understand. Look! more research showing you're wrong! Should we follow the evidence or rando makeup lady? https://t.co/oK14R1lqPF
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/8FTWEqLzOP
RT @JohnHRandall1: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/FMGd9KzNmB
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/FMGd9KzNmB
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/bBg8e2zxq6
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/pyT6pPvPhr
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
@SteveFifield3 @AdamJKucharski @JamesWard73 Source? Overall VE of 2 dose Pfizer vs hospitalization is estimated at 70% in this paper. https://t.co/tIr2idrS8Z
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/vGic3wvJaC
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
Next one, finally published
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/4t3a6dXhmR
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
RT @influenzer3: さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in…
さらに南アフリカでは、ワクチン接種後にも自然曝露によるbooster効果により免疫能が維持されている可能性がある点かと。 Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/iNkzrOhmkL
Ómicron no ayuda con la Ola de pánico: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/uPTd8DGH8R
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Km9aweh0lE
Trend up+6: Collie S, ..., Gray G (N Engl J Med) __Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa__ https://t.co/YkJMeFyvr6
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa https://t.co/Dtwee0dKwx
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @CarlosdelRio7: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa @NEJM https://t.co/2Wrn5R8ifW Although vaccin…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @CarlosdelRio7: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa @NEJM https://t.co/2Wrn5R8ifW Although vaccin…
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/LwYOm8AsEc
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
Trend top+5: Collie S, ..., Gray G (N Engl J Med) __Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa__ https://t.co/YkJMeFyvr6
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/SCJRw49nLz
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM - https://t.co/QhtkGbBFVi https://t.co/B3ner0rVh2 via @GoogleNews
RT @LuisZuritaG: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/KtgL0SGSXo
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/KtgL0SGSXo
RT @JNkengasong: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/Q8cDpMQcWl
RT @CarlosdelRio7: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa @NEJM https://t.co/2Wrn5R8ifW Although vaccin…
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/uVqkCniH3e
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/KpCOC1RCHe
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM https://t.co/pElpoahaoa
RT @DrChoueiri: JUST IN: Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | @NEJM https://t.co/ALoveF1AAM
RT @carpe_diem0820: 南アフリカでファイザーワクチン2回接種による有効性は、オミクロン流行前後で93→70％(95CI 62～76)に低下も、入院に対しては93％(90～94)と維持されていた ブースター接種で更に改善の可能性 Effectiveness o…
org/doi/full/10.1056/NEJMc2119270 ansonsten: Ja, das ist eine gängige Desinformationsstategie dieser Leute. Da steht dann: "Eine Studie kam zum Ergebnis ...
org/doi/full/10.1056/NEJMc2119270 · No photo description ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron Variant in. 4 yrs. 6. Profile photo of Erkko. Erkko Lehtinen.
org/content/10.1101/2021.12.10.21267534v1 https://www.nejm. org/doi/full/10.1056/NEJMc2119270 https://www.discovery.co.za/corporate/news- room https://www ...
https://doi.org/10.1056/NEJMc2119270. https://doi.org/10.4161/hv.36117. Cortés, M., and Georgopoulos, K. (2004). Aiolos is required for the generation Eisen ...
429 doi: 10.1056/NEJMc2119270. pmid:34965358. 17. Accorsi EK, Britton A, Fleming-Dutra KE, Smith ZR, Shang N, Derado G, et al. Association between 3 doses of ...
N. Engl. J. Med. https://doi.org/10.1056/NEJMc2119270 (2021). Gray, G. E. et al. Preprint at medRxiv https ...
series adds further evidence that, as Western Cape, Cape Town, South Africa (TS, MLS) https://doi.org/10.1056/NEJMc2119270. predicted, omicron is able to ...
NEJMc2119270 PMID: 34965358. 17. Accorsi EK, Britton A, Fleming ... https://doi.org/10.1056/NEJMp2119682 PMID: 35108465. 20. Meredith GR ...
org/doi/full/10.1056/NEJMc2119270 https://www.nejm. org/doi/full/10.1056/NEJMoa2119451 « Produit dangereux » Ça il va falloir le démontrer ...
doi:10.1056/NEJMc2119270. 27. Ferdinands JM, Rao S, Dixon BE, et al. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19 ...
... 10.1056/NEJMc2119270. Vaccination Waning: Centers for Disease Control and Prevention. (2022.) “Waning 2-Dose and 3-Dose Effectiveness of mRNA ...
doi:10.1056/NEJMc2119270. 6. Petherick A, Goldszmidt R, Andrade EB, et al. A worldwide assessment of changes in adherence to COVID-19.
... 10.1056/NEJMc2119270. Vaccination Waning: Centers for Disease Control and Prevention. (2022.) “Waning 2-Dose and 3-Dose Effectiveness of mRNA ...
2021;NEJMc2119270. doi:10.1056/NEJMc2119270; Tenforde MW, Patel MM, Ginde AA, et al. Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing ...
... 10.1056/NEJMc2119270;. 10.UK Health Security Agency. COVID-19 Vaccine Surveillance Report - Week 8. 24 February 2022;. 11.Tartof SY, et al ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 3 yrs. 2. Steve Harrison. Sammy Keo I would say ...
doi: 10.1056/nejmc2119270 León TM, Dorabawila V, Nelson L, et al. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and ...
doi:10.1056/nejmc2119270. 9. BFMTV com. Covid-19: l'interview exclusive du patron de Pfizer sur BFMTV. BFMTV. Published January 17, 2022 ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Nicholas J. Evancik. Paul Meier And I am ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Simona Chalupková. Michal Macháč ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 3 年. Shazaam Power. Jasna Kuburic - moreover ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Profile photo of Paul. Paul Lamouret.
https://www.nejm.org/doi/full/10.1056/NEJMc2119270. "During the proxy omicron period, we found a vaccine effectiveness of 70% (95% confidence ...
https://www.nejm. org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs · 1 · Bill Ferguson.
org/doi/pdf/10.1056/NEJMc2119270? articleTools=true https://www.nejm. org/doi/pdf/10.1056/NEJMoa2116063 ?articleTools=true Let me know if you ...
N Engl J Med, 2021, 10.1056/NEJMc2119270. 19. Muik A, Lui BG, Wallisch AK, et al. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA ...
org/doi/full/10.1056/NEJMc2119270 Svo er það náttúrulega önnur umræða um misskiptingu bóluefnis í heiminum. Þessi afbrigði munu skiptast á ...
org/doi/full/10.1056/NEJMc2119270. No photo description available. 3 yrs. 1. Lauren Mae. Michael ten European countries reporting on vaccine ...
org/doi/pdf/10.1056/NEJMoa2117995?arti cleTools=true https ... org/doi/pdf/10.1056/NEJMc2119270?articl eTools=true https://www.nejm ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 3 yrs. Kelly Devine Vance. Jane Mcneely I have ...
series adds further evidence that, as South Africa (TS, MLS) https://doi.org/10.1056/NEJMc2119270. predicted, omicron is able to evade 1 WHO ...
... ://www.nejm. org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs.
... 10.1056/NEJMc2119270) ✓badania z Wielkiej Brytanii: podanie dawki przypominającej zwiększa skuteczność szczepienia w zapobieganiu ...
... 10.1056/NEJMc2119270 (2021). Artículo Google Académico 6. Gray, GE et al. Preimpresión en medRxiv https://doi.org/10.1101/2021.12 ...
https://www.nejm. org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. 3. Rachel Elizabeth ...
org/doi/full/10.1056/nejmoa2108891 https://www.nejm. org/doi/full/10.1056/NEJMc2119270 https://www.factcheck. org/2021/09/covid-19-the ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. David Whyle. The unvaccinated by choice ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Roman A Garcia. Rory, straight out of the ...
Omicron Variant in South Africa. N Engl J Med 2021. DOI: 10.1056/NEJMc2119270. 20. Ferguson N, Ghani A, Cori A, Hogan A, Hinsley W, ...
org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Steve Emery. Annette Huenke https://amp.
Annette Huenke https://www.nejm. org/doi/full/10.1056/NEJMc2119270. nejm.org. Effectiveness of BNT162b2 Vaccine against Omicron. 4 yrs. Steve ...
org/doi/full/10.1056/NEJMc2119270 Do you have any actual evidence that vaccines have “negative efficacy” against omicron? Also, what does ...
... 10.1056/NEJMc2119270 Un alt studiu preliminar din Africa de Sud ce evaluează riscul de spitalizare în rândul personalului medical ...
org/doi/full/10.1056/NEJMc2119270 https://www.ncbi.nlm.nih. gov/pmc/articles/PMC8687472/ https://www.nejm. org/doi/full/10.1056/NEJMc2119358 ...
org/doi/full/10.1056/NEJMc2119270 Un alt studiu preliminar din Africa de Sud ce evaluează riscul de spitalizare în rândul personalului ...
DOI: 10.1056/NEJMc2119270. DOI: 10.1101/2021.12.20.21267966. loading... Frag die KI. Die experimentelle KI von PZ und PTA-Forum. Die ...
org/doi/full/10.1056/NEJMc2119270 The double dose vaccine seems to have an efficacy of reducing symptoms and/or actually contracting the ...
org/doi/full/10.1056/NEJMc2119270 Is this okay to post this from New England journal Journal of Medicine? South Africa average age is 27 ...
org/doi/full/10.1056/NEJMc2119270?s=09. No photo description available. 4 yrs. Profile photo of Ronel. Ronel Horne. But most of this article is ...
org/doi/full/10.1056/NEJMc2119270 · No photo description available. Marcel T Younger. 1 reaction ·. 1 comment. WWLTV. 3y · Public · “The initial ...
I
SM
FO
DS
LG
P
NK
PM
J
G
SD
お
A
SW
AB
DB
MK
M
JV
LK
M
GG
RS
森
EG
JM
Aˎ
つ
B
J
BB
B
DC
KM
A
LL
S
P
DW
ヰ
F
F
論
N
DV
KM
KB
そG
KK
Y
MM
SL
か
NG
AP
が
S
J
UT
P
A
L
D
C
CP
ｋ
吉
T
ピ
フジ
ぽ
D政
S
TE
夜
AK
DH
チあ
さT
ト
A
YG
の
たF
地マ
フ
鬼療
よ条
S
M
N
コH
ち
エ音
み
AC
TL
EG
MP
D
竹花
GG
AV
M
P
S
ぷ
超椰
Z
山
U
こ
え
SA
SM
DC
JT
FZ
SF
HG
S
BC
TW
FM
ES